Department of Health and Human Services. Daily breakfast meal tracker. Lose weight, build strength, have more energy. I have found a great sense of comfort in 20 minutes of meditation daily. Science seems to back up this idea.
Come along to the Summit to meet these companies and other great emerging and established tech and nutrition brands. Neil Grimmer is the founder and CEO of Habit, pioneering personalized nutrition through deep science and food innovation. Today, Neil is on a mission to change the world through food once again — this time for grown-ups. Maghsoodnia brings over 20 years of experience in executive management at public and private companies and had built several technology companies. Maghsoodnia has a Bachelor of Science in Electrical Engineering and Computer Science from University of California, Berkeley, and has done graduate level studies in computer science at Stanford University.
As a committed mountain bike racer, nutritionist, strategic thinker and a type 1 diabetic myself, I believe that measuring aspects of your health, knowing your behavior and using that information for personalized advice will be the future of food and healthcare.
For the Dutch knowledge institute TNO, I set up a large international research consortium together with Wageningen Research that investigates the technical and social innovations that will enable personalized nutrition through consumer empowerment. This pre-competitive public private consortium is unique in combining different scientific expertise across the whole value chain of personalized nutrition and using real world field labs.
I am a keen mountain bike racer and race competitively in the amateur classes myself, run an amateur mountain bike team with a friend of mine and give MTB skills training for a cycling club as a volunteer. Moon Express is the only company to have permission from the US government to leave earth orbit and land on the moon with the goal to harvest planetary resources and to develop infrastructure to make humanity a multi-planetary society. Naveen Jain a trustee of the board at the X PRIZE Foundation where he is focused on using incentive prizes to find solution to many of the societal challenges.
Shai is a serial entrepreneur and engineer by trade. Experienced in development and growth of digital products. He is Passionate about life and the quest for immortality.
I provide consulting services to companies within the personalised nutrition industry. I blend my technical background in nutrition, with business and research skills to develop new products, validate algorithms and connect potential partners. I tend to work closely with the data-science, marketing and management teams to work on specific projects or to go to market.
I also speak 3 languages and recently taught my two young kids to dance the Macarena. He grew up in France and moved to the US with Deloitte in He spent 12 years in the health technology sector where he developed a passion for products at the intersection of science and technology with a mission. The mission of InsideTracker is to transform the way every human being eats, sleeps, and moves to live a longer, better life.
You can find the company at insidetracker. Please do download the agenda to find out more information about the Summit including the main topics of discussion for the two days and our full lineup of speakers. We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.
STYR is a personalized nutrition as a service app that links and syncs to connected devices STYR devices or most others in the market to track activity, hydration and body composition. Couple this with your food choices via our voice activated food logging and quick logging sleep and mood data, and you paint a holistic picture of yourself through STYR that enables our platform to recommend nutritional products to balance your diet and lifestyle.
Vitagene is a DNA-based personalization platform for health and wellness. Today the company offers diet, fitness and supplementation plans through an online portal and partners with premier brands to tailor their product offering for our customers based on their individual needs.
By providing easy, affordable access to genetic information and personalized guidance on how to use it, we help individuals make educated and proactive lifestyle choices leading to better health outcomes. Based in San Francisco, the company has a team of accomplished entrepreneurs, scientists and physicians, and was founded in At Tespo, we are flipping an entire industry on its head by empowering consumers through innovative health technology.
Our personal health and wellness system will be the most advanced to-date — features include:. The relationships we forge with our customers are at a deep and meaningful level; something the vitamin industry has never seen before. Our platform was built to ensure that we provide our customers with quality solutions by leveraging their data in order to make highly informed, highly personalized recommendations.
Nutrition without the guesswork. We provide personalized nutrition and actionable insights that allow you to live healthier and maintain normal blood sugar levels. Discover surprising food possibilities, while living your life with smarter nutritional and activity choices. We do this by studying your individual metrics and gut microbiome — that vast collection of bacteria that you host. Turns out your microbiome has a big impact on your health, and we translate your unique gut bacteria into personalized actionable insights.
Monteloeder is a biotech company with more than 20 years of experience developing scientifically proven health ingredients. During the last 4 years we have been working on a new concept for the industry, Digitalization of health ingredients. The new developmental methods that we apply are focused in discovering the ideal solution for each consumer and adapt our strategy towards it.
Listening to the consumers, understanding their needs and habits, so that we can offer the best personalized solutions for them. Our digital solutions are designed to provide our B2B partners with the right tools to implement a consumer centric strategy. Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. Our deep clinical knowledge supports specialty ingredients with proven performance, enabling customers to address consumer health concerns via new, differentiated health products.
A recent study estimated that ex-smokers make between 6 and 30 attempts before successfully quitting.
The US Guideline specifies that three combinations of medications are effective: Gradual reduction involves slowly reducing one's daily intake of nicotine. This can theoretically be accomplished through repeated changes to cigarettes with lower levels of nicotine, by gradually reducing the number of cigarettes smoked each day, or by smoking only a fraction of a cigarette on each occasion. A systematic review by researchers at the University of Birmingham found that gradual nicotine replacement therapy could be effective in smoking cessation.
Most smoking cessation resources such as the CDC  and Mayo Clinic  encourage smokers to create a quit plan, including setting a quit date, which helps them anticipate and plan ahead for smoking challenges.
A Cochrane review found evidence that community interventions using "multiple channels to provide reinforcement, support and norms for not smoking" had an effect on smoking cessation outcomes among adults.
A Cochrane review found that self-help materials may produce only a small increase in quit rates. Various methods exist which allow a smoker to see the impact of their tobacco use, and the immediate effects of quitting. Using biochemical feedback methods can allow tobacco-users to be identified and assessed, and the use of monitoring throughout an effort to quit can increase motivation to quit.
While both measures offer high sensitivity and specificity, they differ in usage method and cost. As an example, breath CO monitoring is non-invasive, while cotinine testing relies on a bodily fluid. These two methods can be used either alone or together, for example, in a situation where abstinence verification needs additional confirmation. Financial or material incentives to entice people to quit smoking improves smoking cessation while the incentive is in place.
A different Cochrane review found that one type of competition, "Quit and Win," did increase quit rates among participants. Interventions delivered via healthcare providers and healthcare systems have been shown to improve smoking cessation among people who visit those services.
Although smoking prevalence has declined in recent years leading up to , certain subpopulations continue to smoke at disproportionately high rates and show resistance to cessation treatments. A Cochrane review, mainly of studies combining motivational enhancement and psychological support, concluded that "complex approaches" for smoking cessation among young people show promise. Smoking during pregnancy can cause adverse health effects in both the woman and the fetus. The US Guideline determined that "person-to-person psychosocial interventions" typically including "intensive counseling" increased abstinence rates in pregnant women who smoke to Their babies are often underdeveloped, have smaller organs, and weigh much less than the normal baby.
In addition, these babies have weaker immune systems, making them more susceptible to many diseases such as middle ear inflammations and asthmatic bronchitis, which can bring significant morbidity. There is also an increased chance that the child will be a smoker in adulthood.
A systematic review showed that psychosocial interventions help women to stop smoking in late pregnancy and can reduce the incidence of low birthweight infants. It is a myth that a female smoker can cause harm to a fetus by quitting immediately upon discovering she is pregnant. This idea is not based on any medical study or fact. Studies across 20 countries show a strong association between patients with schizophrenia and smoking. People with schizophrenia are much more likely to smoke than those without the disease.
A Cochrane review of smoking cessation activities in work-places concluded that "interventions directed towards individual smokers increase the likelihood of quitting smoking,". Smokers who are hospitalised may be particularly motivated to quit. Patients undergoing elective surgery may get benefits of preoperative smoking cessation interventions, when starting 4—8 weeks before surgery with weekly counselling intervention for behavioral support and use of nicotine replacement therapy.
People who have mood disorders or attention deficit hyperactivity disorders have a greater chance to begin smoking and lower chance to quit smoking. Homelessness doubles the likelihood of an individual currently being a smoker. This is independent of other socioeconomic factors and behavioral health conditions. Homeless individuals have the same rates of the desire to quit smoking but are less likely than the general population to be successful in their attempt to quit.
Americans under the poverty line have higher rates of smoking and lower rates of quitting than those over the poverty line. These unique barriers can be combated thusly: Comparison of success rates across interventions can be difficult because of different definitions of "success" across studies. A systematic review in the European Journal of Cancer Prevention found that group behavioural therapy was the most effective intervention strategy for smoking cessation, followed by bupropion , intensive physician advice, nicotine replacement therapy, individual counselling, telephone counselling, nursing interventions, and tailored self-help interventions; the study did not discuss varenicline.
Quitting can be harder for individuals with dark pigmented skin compared to individuals with pale skin since nicotine has an affinity for melanin -containing tissues. Studies suggest this can cause the phenomenon of increased nicotine dependence and lower smoking cessation rate in darker pigmented individuals.
There is an important social component to smoking. A study of a densely interconnected network of over 12, individuals found that smoking cessation by any given individual reduced the chances of others around them lighting up by the following amounts: Smokers who are trying to quit are faced with social influences that may persuade them to conform and continue smoking.
Cravings are easier to detain when one's environment does not provoke the habit. If a person who stopped smoking has close relationships with active smokers, he or she is often put into situations that make the urge to conform more tempting. However, in a small group with at least one other not smoking, the likelihood of conformity decreases. The social influence to smoke cigarettes has been proven to rely on simple variables. One researched variable depends on whether the influence is from a friend or non-friend.
Therefore, if an acquaintance offers a cigarette as a polite gesture, the person who has stopped smoking will be more likely to break his commitment than if a friend had offered.
Recent research from the International Tobacco Control ITC Four Country Survey of over 6, smokers found that smokers with fewer smoking friends were more likely to intend to quit and to succeed in their quit attempt. Expectations and attitude are significant factors. A self-perpetuating cycle occurs when a person feels bad for smoking yet smokes to alleviate feeling bad. Breaking that cycle can be a key in changing the sabotaging attitude.
Smokers with major depressive disorder may be less successful at quitting smoking than non-depressed smokers. Relapse resuming smoking after quitting has been related to psychological issues such as low self-efficacy ,   or non-optimal coping responses;  however, psychological approaches to prevent relapse have not been proven to be successful.
In a review of the effects of abstinence from tobacco, Hughes concluded that "anger, anxiety, depression, difficulty concentrating, impatience, insomnia, and restlessness are valid withdrawal symptoms that peak within the first week and last 2—4 weeks. Giving up smoking is associated with an average weight gain of 4—5 kilograms 8. The Guideline suggests that sustained-release bupropion, nicotine gum, and nicotine lozenge be used "to delay weight gain after quitting. Like other physically addictive drugs, nicotine addiction causes a down-regulation of the production of dopamine and other stimulatory neurotransmitters as the brain attempts to compensate for the artificial stimulation caused by smoking.
Therefore, when people stop smoking, depressive symptoms such as suicidal tendencies or actual depression may result,   although a recent international study comparing smokers who had stopped for 3 months with continuing smokers found that stopping smoking did not appear to increase anxiety or depression. A recent study by The British Journal of Psychiatry has found that smokers who successfully quit feel less anxious afterward with the effect being greater among those who had mood and anxiety disorders than those that smoked for pleasure.
Many of tobacco's detrimental health effects can be reduced or largely removed through smoking cessation. The health benefits over time of stopping smoking include: The British Doctors Study showed that those who stopped smoking before they reached 30 years of age lived almost as long as those who never smoked.
A Systematic Review and Meta-analysis," examined six randomized trials and 15 observational studies to look at the effects of preoperative smoking cessation on postoperative complications. Cost-effectiveness analyses of smoking cessation activities have shown that they increase quality-adjusted life years QALYs at costs comparable with other types of interventions to treat and prevent disease.
The frequency of smoking cessation among smokers varies across countries. Smoking cessation increased in Spain between and ,  in Scotland between and ,  and in Italy after Nevertheless, in a growing number of countries there are now more ex-smokers than smokers  For example, in the U.
From Wikipedia, the free encyclopedia. International Journal of Advanced Research. Morbidity and Mortality Weekly Report. British Journal of Nursing. Retrieved 22 October WHO Report on the global tobacco epidemic. The Cochrane Database of Systematic Reviews. N Engl J Med. Clinical practice guideline no. Archived from the original PDF on Nicotine and Tobacco Research. Am J Public Health. Do cessation programs help? What do I need to know about quitting" PDF. Check date values in: Stead, Lindsay F, ed.
Cochrane Database Syst Rev 1: Smokers quit cold turkey". The Cochrane Database of Systematic Reviews 2: Cochrane Database of Systematic Reviews.